New cancer clinical trial: A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

Published on: January 28, 2019 at 12:00PM
Condition:   Metastatic Non-Small Cell Lung Cancer (NSCLC)
Interventions:   Drug: Durvalumab;   Drug: Danvatirsen;   Drug: Oleclumab;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Nab-paclitaxel
Sponsor:   AstraZeneca
Recruiting
http://bit.ly/2RldZ24